Every lot of GLP-3 / Tesa / Cagri is tested by an independent ISO/IEC 17025-accredited lab in the USA. 99%+ purity isn't a target here. It's the requirement.
Don't take our word for it: test any vial at an accredited lab of your choice. If HPLC purity comes back under 99%, we refund your order and pay for the test.
This is a blend. GLP-3, Tesamorelin and Cagri are combined in a single 17.5 mg vial at 10 mg, 5 mg and 2.5 mg respectively. It places a triple-receptor incretin compound, a growth-hormone-releasing-hormone analog and an amylin analog in one vial. The three are characterised separately in the literature; the combination has not been characterised as a single entity.
The numbers that define GLP-3 / Tesa / Cagri and how it is being studied. For laboratory research use only.
3
Research Compounds
GLP-3 · Tesa · Cagri
17.5 mg
Total Per Vial
10 mg + 5 mg + 2.5 mg
3
Pathway Arms
Incretin · GH axis · amylin
4
Research Areas
Energy balance
GH-axis signalling
Lipid metabolism
How It Works
How GLP-3 / Tesa / Cagri works
The pathways GLP-3 / Tesa / Cagri acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Triple Receptor Activity
GLP-3
Agonism at the GIP, GLP-1 and glucagon receptors is characterised, with energy-expenditure and hepatic-lipid endpoints measured alongside the incretin readouts.
GIP · GLP-1 · glucagon
Energy expenditure
Hepatic lipid measures
GHRH-Axis Signalling
Tesa
Tesamorelin is a GHRH analog studied for pulsatile growth-hormone release and downstream IGF-1 measures in GH-axis research.
GHRH receptor engagement
Pulsatile GH release
IGF-1 endpoints
Amylin Receptor Signalling
Cagri
Satiety signalling and gastric-emptying rate are the characterised endpoints for amylin analogs.
Amylin receptor complexes
Satiety signalling
Gastric-emptying rate
Uses & Applications
What GLP-3 / Tesa / Cagri is researched for
The main areas GLP-3 / Tesa / Cagri is being studied for - and the study-reported figures behind them.
Metabolic
Energy Balance Models
Energy-expenditure endpoints are characterised for the glucagon-receptor arm.
Endocrinology
GH-Axis Research
Tesamorelin is studied for GHRH-receptor engagement and downstream IGF-1 measures.
Metabolic
Satiety Signalling
The amylin arm carries satiety and gastric-emptying endpoints.
Methods
Three-Arm Protocols
One vial holds three distinct pathway arms under matched handling.
Study-reported magnitudes
Representative figures from published research. Bars fill as you scroll.
Triple Receptor EngagementCharacterised
GH-Axis Signalling (Tesa)Characterised
Amylin Signalling (Cagri)Characterised
Blend Interaction DataNone
Figures are representative of published research findings and shown for reference.
Molecular Structure
The GLP-3 / Tesa / Cagri molecule
An interactive 3D model rendered from the compound record - rotate and explore its structure.
Molecular model
Sequence length
blend
Physical form
Lyophilized powder blend
Documented purity
≥99% by HPLC
Compound Information
Full specification
Components
GLP-3 + Tesamorelin + Cagri
Content
17.5 mg per vial (10 mg + 5 mg + 2.5 mg)
Pathways
Incretin · GHRH axis · amylin
Form
Lyophilized powder blend
Purity
≥99% by HPLC
Appearance
White to off-white powder
Solubility
Water-soluble
Storage
-20°C, protected from light
Classification
Research use only
FAQ
Common questions about GLP-3 / Tesa / Cagri
They cover three separate pathways: multi-receptor incretin signalling, the GHRH axis, and amylin signalling. The vial holds all three under matched handling.
No. Each compound is characterised separately and no interaction data exists for the three together.
The ratio follows the supplier's formulation at 10 mg, 5 mg and 2.5 mg. It is fixed and cannot be varied within the vial.
Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.
Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.
Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
